August 22, 2025

Nemolizumab Study Tracks 68 Weeks of Relief

A long-term clinical study finds that the biologic therapy nemolizumab, when used with topical corticosteroids, continues to improve itch, sleep, and skin symptoms in prurigo nodularis patients over 68 weeks.

Conexiant

August 21, 2025

Medical Oddities: Puberty’s Hidden Fine Print

Puberty timing, feline brains, tea habits, sweat patches, and stings unite in this week’s medical grab bag.

Conexiant

August 14, 2025

Thai Trial Tests Turmeric Emulgel Skin Safety

Thai investigators test a botanical emulgel formulation to identify early safety signals related to skin irritation and allergenicity before advancing to patient trials.

Conexiant

August 13, 2025

Medical Oddities: Spud Alert, Method Matters Most

Science spans snacks, cells, sheep, and sips in this week’s research highlights.

Conexiant

November 01, 2024

Are Toothbrushes More Viral Than Showerheads?

Study finds your toothbrush hosts primarily human-associated bacteria including Klebsiella, Streptococcus, and Veillonella, while showerheads harbor environmental microbes.

Conexiant

January 07, 2025

Patient Insights on HRQOL in Chronic GVHD

Explore how cutaneous graft-versus-host disease impacts patients’ quality of life across physical, psychological, and social domains.

Conexiant

May 21, 2025

Medical Oddities: Fingernail Selfies Spot Anemia

Tea, tech, TikTok & toxins: surprising health twists hiding in phones, roads, and skin care.

Conexiant

May 28, 2025

Kennedy Proposes NIH Publishing Ban

"We're probably going to stop publishing in The Lancet, New England Journal of Medicine, JAMA, and those other journals because they're all corrupt."

Conexiant

September 09, 2024

First Full Eye, Face Transplant Performed

In a surgical first, retinal cells showed light responsiveness up to 9.0 μv at 220 days after whole eye transplant, nearing the low end of normal (10-50 μv).

Conexiant